Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center

Detalles Bibliográficos
Autores principales: Borogovac, Azra, Keruakous, Amany, Bycko, Michelle, Holter Chakrabarty, Jennifer, Ibrahimi, Sami, Khawandanah, Mohamad, Selby, George B., Yuen, Carrie, Schmidt, Sarah, Autry, Marcus T., Al-Juhaishi, Taha, Wieduwilt, Matthew J., Asch, Adam S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995917/
https://www.ncbi.nlm.nih.gov/pubmed/35411106
http://dx.doi.org/10.1038/s41409-022-01664-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995917/
https://www.ncbi.nlm.nih.gov/pubmed/35411106
http://dx.doi.org/10.1038/s41409-022-01664-z

Ejemplares similares